论文部分内容阅读
目的:探究血红蛋白和红细胞在甲减患者中的诊断意义。方法:选取2015年3月~2016年3月我院接受治疗的50例甲减患者作为观察组,同期选取50例健康体检者作为对照组,采用全自动血细胞分析仪对两组患者的血红蛋白和观察组患者的红细胞水平进行检测,而后观察并分析两组患者的血红蛋白、红细胞水平,甲状腺激素水平和观察组患者的贫血分级结果。结果:观察组患者的血红蛋白、红细胞水平和甲状腺激素水平明显高于对照组,两组患者的血红蛋白、红细胞水平,甲状腺激素水平具有一定的差异(P<0.05),统计学意义显著。观察组中轻度贫血的患者有6例、中度贫血的患者有8例、轻度贫血的患者有4例、无贫血的患者有32例。结论:甲减患者在治疗的过程中容易发生贫血,因此,对患者的血红蛋白和红细胞水平进行动态监测,可有效的提高患者的治疗效果,为该病患者的治疗提供较为科学的临床价值,值得临床信赖。
Objective: To investigate the diagnostic significance of hemoglobin and erythrocytes in patients with hypothyroidism. Methods: 50 cases of hypothyroidism treated in our hospital from March 2015 to March 2016 were selected as the observation group. Fifty healthy subjects were selected as control group during the same period. The hemoglobin and hemoglobin The level of erythrocyte in the observation group was detected. Then, the hemoglobin, erythrocyte level, thyroid hormone level and anemia grade in the observation group were observed and analyzed. Results: The levels of hemoglobin, erythrocyte and thyroid hormone in the observation group were significantly higher than those in the control group. The hemoglobin, erythrocyte level and thyroid hormone level in the two groups were significantly different (P <0.05). The statistical significance was significant. In the observation group, there were 6 mild anemia patients, 8 moderate anemia patients, 4 mild anemia patients and 32 anemia-free patients. Conclusion: Patients with hypothyroidism are prone to anemia during the course of treatment. Therefore, the dynamic monitoring of hemoglobin and erythrocyte level in patients can effectively improve the therapeutic effect of the patients and provide more scientific value for the treatment of the patients, which is worth Clinical trust.